CO6331309A2 - Derivados 6-heterociclico-imidazo[1,2-alfa]piridina-2-carboxamidas su preparacion y su aplicacion en terapeutica - Google Patents

Derivados 6-heterociclico-imidazo[1,2-alfa]piridina-2-carboxamidas su preparacion y su aplicacion en terapeutica

Info

Publication number
CO6331309A2
CO6331309A2 CO10080887A CO10080887A CO6331309A2 CO 6331309 A2 CO6331309 A2 CO 6331309A2 CO 10080887 A CO10080887 A CO 10080887A CO 10080887 A CO10080887 A CO 10080887A CO 6331309 A2 CO6331309 A2 CO 6331309A2
Authority
CO
Colombia
Prior art keywords
group
alkyl
alkoxy
halogen
alkyl group
Prior art date
Application number
CO10080887A
Other languages
English (en)
Inventor
Jean Francois Peyronel
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Publication of CO6331309A2 publication Critical patent/CO6331309A2/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/0803Compounds with Si-C or Si-Si linkages
    • C07F7/081Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
    • C07F7/0812Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring
    • C07F7/0814Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring said ring is substituted at a C ring atom by Si
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/22Tin compounds
    • C07F7/2208Compounds having tin linked only to carbon, hydrogen and/or halogen

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Addiction (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

1.- Compuestos de formula (I)en la que:X representa un grupo fenilo sustituido opcionalmente con uno o varios grupos elegidos independientemente los unos de los otros entre los átomos o grupos siguientes:halógeno, alcoxi(C1-C6), alquilo(C1-C6), NRaRb, ciano, alcoxi(C1-C6)carbonilo, estando los grupos alquilo(C1-C6) y alcoxi(C1-C6) sustituidos opcionalmente con uno 10 o varios átomos de halógeno;R1, representa un átomo de hidrógeno, un halógeno, un grupo alcoxi(C1-C6), un grupo alquilo(C1-C6), un grupo NRaRb; pudiendo estar los grupos alquilo y alcoxi sustituidos opcionalmente con uno o varios halógeno, hidroxi, amino o grupo alcoxi(C1-C6);R2 representa un grupo heterocíclico aromático, insaturado, parcialmente saturado o totalmente saturado, sustituido opcionalmente con uno o varios grupos elegidos independientemente los unos de los otros entre los átomos o grupos siguientes:hidroxi, alcoxi(C1-C6), halógeno, ciano, NRaRb, -CO-R5, -CO-NR6R7, -CO-O-R8, -NR9-CO-R10 cicloalquilo(C3-C7)alquilo(C1-C6), cicloalquilo(C3-C7)alcoxi C1-C6), un grupo alquilo(C1-C6), sustituido opcionalmente con uno o varios hidroxi o NRaRb, un grupo óxido;R3; representa un átomo de hidrógeno, u11 grupo alquilo(C1-C6), un grupo alcoxi(C1-C6) o un átomo de halógeno; R4 representa un átomo de hidrógeno, un grupo alquilo(C1-C4), un grupo alcoxi(C1-C4) o un átomo de flúor; R5 representa un átomo de hidrógeno, un grupo fenilo o un grupo alquilo(C1-C6);R6 y R7, idénticos o diferentes, representan un átomo de hidrógeno o un grupo alquilo(C1-C6)o forman con el átomo de nitrógeno u11 ciclo de 4 a 7 eslabones que incluye opcionalmente otro heteroátomo elegido entre N, O o S;R8 representa un grupo alquilo(C1-C6);R9 y R10, idénticos o diferentes, representan un átomo de hidrógeno o un grupo alquilo(C1-C6);Ra y Rb son independientemente el uno del otro, hidrógeno alquilo(C1-C6) o forman con el átomo de nitrógeno al que están unidos un ciclo de 4 a 7 eslabones, que incluye opcionalmente otro heteroátomo elegido entre N, O o S;con la excepción de N-(4-bromofenil)-6-(1-metil-2- piperidinil)imidazo[1,2-a]piridina-2-carboxamida;en el estado de base o de sal de adición a un ácido.
CO10080887A 2008-01-02 2010-07-02 Derivados 6-heterociclico-imidazo[1,2-alfa]piridina-2-carboxamidas su preparacion y su aplicacion en terapeutica CO6331309A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0800005A FR2925903B1 (fr) 2008-01-02 2008-01-02 DERIVES 6-HETEROCYCLIQUE-IMIDAZO°1,2-a!PYRIDINE-2- CARBOXAMIDES, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE

Publications (1)

Publication Number Publication Date
CO6331309A2 true CO6331309A2 (es) 2011-10-20

Family

ID=39745373

Family Applications (1)

Application Number Title Priority Date Filing Date
CO10080887A CO6331309A2 (es) 2008-01-02 2010-07-02 Derivados 6-heterociclico-imidazo[1,2-alfa]piridina-2-carboxamidas su preparacion y su aplicacion en terapeutica

Country Status (25)

Country Link
US (2) US8314109B2 (es)
EP (1) EP2225240B1 (es)
JP (1) JP5258899B2 (es)
KR (1) KR101600635B1 (es)
CN (1) CN101959884B (es)
AR (1) AR070074A1 (es)
AU (1) AU2008351928B2 (es)
BR (1) BRPI0821458A2 (es)
CA (1) CA2710947C (es)
CL (1) CL2008003928A1 (es)
CO (1) CO6331309A2 (es)
EA (1) EA019122B1 (es)
FR (1) FR2925903B1 (es)
HK (1) HK1148016A1 (es)
IL (1) IL206669A (es)
MA (1) MA32527B1 (es)
ME (1) ME01157B (es)
MX (1) MX2010007353A (es)
MY (1) MY155468A (es)
NZ (1) NZ586474A (es)
SG (1) SG187408A1 (es)
TW (1) TWI432432B (es)
UY (1) UY31589A1 (es)
WO (1) WO2009106750A2 (es)
ZA (1) ZA201004644B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2925907B1 (fr) * 2008-01-02 2010-10-15 Sanofi Aventis DERIVES DE 2-HETEROAROYL-IMIDAZO°1,2-a!PYRIDINE, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE
CA2852615A1 (en) * 2011-10-21 2013-04-25 Torrent Pharmaceuticals Limited Novel substituted imidazopyrimidines as gpbar1 receptor modulators
KR101716993B1 (ko) 2012-12-25 2017-03-15 닛뽕소다 가부시키가이샤 할로겐화 아닐린 및 그 제조 방법
CN108295074B (zh) * 2018-02-01 2020-08-28 华中农业大学 一种噻二唑并三嗪类化合物在制备单胺氧化酶抑制剂中的用途

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2638161B1 (fr) * 1988-10-24 1991-01-11 Centre Nat Rech Scient Nouvelles benzoyl-2 imidazo (1,2-a) pyridines et leurs sels, leur procede de preparation, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant
IE904346A1 (en) * 1989-12-04 1991-06-05 Searle & Co IMIDAZO[1,2-a]PYRIDINYLALKYL COMPOUNDS FOR TREATMENT OF¹NEUROTOXIC INJURY
AU2003269354B2 (en) * 2002-09-24 2008-03-06 Neuro Therapeutics Ab Methods for promoting dopaminergic neuronal development by using NG4A-subfamily and Wnt-ligands
EP1567527A1 (en) * 2002-11-27 2005-08-31 Eli Lilly And Company Condensed pyrazolo derivatives
WO2004103991A1 (fr) * 2003-05-20 2004-12-02 'chemical Diversity Research Institute', Ltd. Piperidines 2-substituees, bibliotheque focalisee et composition pharmaceutique
DE102005019181A1 (de) * 2005-04-25 2006-10-26 Novartis Ag Peptid-Deformylase (PDF) Inhibitoren 1
FR2903108B1 (fr) * 2006-07-03 2008-08-29 Sanofi Aventis Sa Utilisation de derives d'imidazo[1,2-a] pyridine-2-carboxamides en therapeutique.
FR2903107B1 (fr) * 2006-07-03 2008-08-22 Sanofi Aventis Sa Derives d'imidazopyridine-2-carboxamides, leur preparation et leur application en therapeutique
FR2903106B1 (fr) * 2006-07-03 2010-07-30 Sanofi Aventis Utilisations de 2-benzoyl-imidazopyridines en therapeutique

Also Published As

Publication number Publication date
MA32527B1 (fr) 2011-08-01
CA2710947A1 (fr) 2009-09-03
IL206669A0 (en) 2010-12-30
EP2225240B1 (fr) 2014-01-22
JP5258899B2 (ja) 2013-08-07
MY155468A (en) 2015-10-15
ME01157B (me) 2013-03-20
US8314109B2 (en) 2012-11-20
ZA201004644B (en) 2011-11-30
EP2225240A2 (fr) 2010-09-08
TW200934780A (en) 2009-08-16
TWI432432B (zh) 2014-04-01
MX2010007353A (es) 2010-08-18
AU2008351928B2 (en) 2013-11-21
EA019122B1 (ru) 2014-01-30
CN101959884B (zh) 2013-02-27
AU2008351928A1 (en) 2009-09-03
CN101959884A (zh) 2011-01-26
NZ586474A (en) 2012-06-29
KR20100109940A (ko) 2010-10-11
CA2710947C (fr) 2016-04-12
AR070074A1 (es) 2010-03-10
SG187408A1 (en) 2013-02-28
WO2009106750A3 (fr) 2010-02-25
FR2925903B1 (fr) 2011-01-21
CL2008003928A1 (es) 2010-02-12
EA201070814A1 (ru) 2011-02-28
US20100317675A1 (en) 2010-12-16
US20130041152A1 (en) 2013-02-14
FR2925903A1 (fr) 2009-07-03
WO2009106750A2 (fr) 2009-09-03
UY31589A1 (es) 2009-08-03
BRPI0821458A2 (pt) 2015-06-16
JP2011508760A (ja) 2011-03-17
HK1148016A1 (es) 2011-08-26
IL206669A (en) 2015-07-30
KR101600635B1 (ko) 2016-03-07
US8691990B2 (en) 2014-04-08

Similar Documents

Publication Publication Date Title
AR087328A1 (es) Derivados de imidazo[1,2-b]piridazina e imidazo[4,5-b]piridina como inhibidores de jak
ES2624795T3 (es) Derivados de N-(heteroaril)-1-heteroaril-1H-indol-2-carboxamidas, su preparación y su aplicación en terapéutica
CR10643A (es) DERIVADOS DE 2-ARIL-6-FENIL-IMIDAZOL[1,2-a]PIRIDINAS, SU PREPARACION Y SU APLICACION EN TERAPEUTICA
AR089774A1 (es) Derivados de indolizina, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen
PA8764301A1 (es) Derivados de n-(amino-heteroaril)-1h-pirrolopiridin-2-carboxamidas, su preparacion y su aplicacion en terapeutica
NO20076006L (no) Acetylenderivater
CO6290657A2 (es) Derivados polisustituidos de 2-aril-6-fenil-imidazo[1,2-alfa]piridinas su preparacion y su aplicacion en terapeutica
PE20170003A1 (es) Compuestos heterociclicos y usos de los mismos
AR067757A1 (es) Derivados de imidazo[4,5-c]piridin-2-ona, composiciones farmaceuticas que los contienen, procedimiento para su preparacion y uso de los mismos como agentes antivirales.
ECSP088105A (es) Derivados de n-(arilalquil)-1h-pirrolopiridin-2-carboxamidas, su preparación y su aplicación en terapéutica
PE20110835A1 (es) Piridiloxi-indoles inhibidores del vegf-r2 y uso de los mismos para el tratamiento de enfermedades
AR054725A1 (es) Pirazolopiridinas y sales de las mismas, una composicion farmaceutica que comprende dichos compuestos, un metodo para prepararlos y su uso
ECSP066415A (es) 2-carbonilamino-6-piperidinaminopiridinas sustituidas y 1-carbonilamino-3-piperidinaminobenzenos sustituidos como 5-ht1f agonistas
CY1111868T1 (el) Παραγωγα ιμιδαζο[1,2-α] πυριδινο-2-καρβοξαμιδιων η παρασκευη τους και η εφαρμογη τους στη θεραπευτικη
NO20052710L (no) Nye imidazopyridinforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem
AR070648A1 (es) Derivados de bencimidazol sustituido
NI200800015A (es) Derivados de n-(heteroaril)-1-heteroarilalquil - 1h - indol - 2 - carboxamidas, su preparación y su aplicación en terapéutica.
PE20141352A1 (es) Fenil-3-aza-biciclo[3,1,0]hex-3-il-metanonas y su uso como medicamento
CO6362007A2 (es) Derivados de azaspiranil-alquilcarbamatos de heterociclos de 5 eslabones, su preparación y su aplicación en terapeútica
EA201170094A1 (ru) Производные замещенного пиримидо[2,1-а]изохинолин-4-она
AR066605A1 (es) Derivados de heteroarilamida pirimidona
AR079077A1 (es) Derivados de piridino-piridinonas, su preparacion y su aplicacion en terapeutica de enfermedades mediadas por la tirosina quinasa
CO6331309A2 (es) Derivados 6-heterociclico-imidazo[1,2-alfa]piridina-2-carboxamidas su preparacion y su aplicacion en terapeutica
AR070438A1 (es) Derivados de 3- aminoalquil -1,3- dihidro -2h indol-2- ona su preparacion y su aplicacion en terapeutica
CO6331307A2 (es) Derivados de imidazo[1,2alfa]piridin-2-carboxamidas su preparacion y su aplicacion en terapeutica

Legal Events

Date Code Title Description
FG Application granted